164 related articles for article (PubMed ID: 37632189)
1. The 675-nm wavelength for treating facial melasma.
Coricciati L; Gabellone M; Donne PD; Pennati BM; Zingoni T
Skin Res Technol; 2023 Aug; 29(8):e13434. PubMed ID: 37632189
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
[TBL] [Abstract][Full Text] [Related]
3. A New 675 nm Laser Device in the Treatment of Melasma: Results of a Prospective Observational Study.
Nisticò SP; Tolone M; Zingoni T; Tamburi F; Scali E; Bennardo L; Cannarozzo G
Photobiomodul Photomed Laser Surg; 2020 Sep; 38(9):560-564. PubMed ID: 32833576
[No Abstract] [Full Text] [Related]
4. Fractional 1064 nm Picosecond Laser in Treatment of Melasma and Skin Rejuvenation in Asians, A Prospective Study.
Wong CSM; Chan MWM; Shek SYN; Yeung CK; Chan HHL
Lasers Surg Med; 2021 Oct; 53(8):1032-1042. PubMed ID: 33544930
[TBL] [Abstract][Full Text] [Related]
5. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic outcome of melasma treatment by dual-wavelength (511 and 578 nm) laser in patients with skin phototypes III-V.
Eimpunth S; Wanitphakdeedecha R; Triwongwaranat D; Varothai S; Manuskiatti W
Clin Exp Dermatol; 2014 Apr; 39(3):292-7. PubMed ID: 24635063
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Low Energy, Low Density, Non-Ablative Fractional 1927 nm Wavelength Laser for Facial Skin Resurfacing.
Brauer JA; Alabdulrazzaq H; Bae YS; Geronemus RG
J Drugs Dermatol; 2015 Nov; 14(11):1262-7. PubMed ID: 26580875
[TBL] [Abstract][Full Text] [Related]
8. Could 675-nm Laser Treatment Be Effective for Facial Melasma Even in Darker Phototype?
Bonan P; Verdelli A; Pieri L; Fusco I
Photobiomodul Photomed Laser Surg; 2021 Oct; 39(10):634-636. PubMed ID: 34597175
[No Abstract] [Full Text] [Related]
9. Investigating the efficacy of a fractionated 1927 nm laser for diffuse dyspigmentation and actinic changes.
Vingan NR; Panton JA; Barillas J; Lazzarini A; Hoopman J; Kenkel JM; Culver A
Lasers Surg Med; 2023 Apr; 55(4):344-358. PubMed ID: 36950878
[TBL] [Abstract][Full Text] [Related]
10. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
11. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
Wattanakrai P; Mornchan R; Eimpunth S
Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
[TBL] [Abstract][Full Text] [Related]
12. Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma.
Choi M; Choi JW; Lee SY; Choi SY; Park HJ; Park KC; Youn SW; Huh CH
J Dermatolog Treat; 2010 Jul; 21(4):224-8. PubMed ID: 20509814
[TBL] [Abstract][Full Text] [Related]
13. A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin.
Kim HS; Kim EK; Jung KE; Park YM; Kim HO; Lee JY
J Cosmet Laser Ther; 2013 Jun; 15(3):143-9. PubMed ID: 23607714
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature.
Garg S; Vashisht KR; Makadia S
J Cosmet Laser Ther; 2019 Aug; 21(5):297-307. PubMed ID: 31010346
[No Abstract] [Full Text] [Related]
15. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.
Lima EVA; Lima MMDA; Paixão MP; Miot HA
BMC Dermatol; 2017 Nov; 17(1):14. PubMed ID: 29183309
[TBL] [Abstract][Full Text] [Related]
16. Pulsed alexandrite laser for treatment of melasma in Asian patients.
Cheng CY; Huang YL; Lee MC; Chang SL; Lin YF; Hu S
J Cosmet Laser Ther; 2017 Aug; 19(4):210-214. PubMed ID: 28151024
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians.
Kung KY; Shek SY; Yeung CK; Chan HH
Lasers Surg Med; 2019 Jan; 51(1):14-22. PubMed ID: 30357871
[TBL] [Abstract][Full Text] [Related]
18. Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin.
Hong SP; Han SS; Choi SJ; Kim MS; Won CH; Lee MW; Choi JH; Moon KC; Kim YJ; Chang SE
J Cosmet Laser Ther; 2012 Apr; 14(2):81-6. PubMed ID: 22372386
[TBL] [Abstract][Full Text] [Related]
19. Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser.
Abdel Hay R; Mohammed FN; Sayed KS; Abd El Fattah NA; Ibrahim S
Dermatol Ther; 2020 Jul; 33(4):e13629. PubMed ID: 32431000
[TBL] [Abstract][Full Text] [Related]
20. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
Lueangarun S; Namboonlue C; Tempark T
J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
